vs
Cellectis S.A.（CLLS）与LIGHTPATH TECHNOLOGIES INC（LPTH）财务数据对比。点击上方公司名可切换其他公司
LIGHTPATH TECHNOLOGIES INC的季度营收约是Cellectis S.A.的1.7倍（$16.4M vs $9.5M），LIGHTPATH TECHNOLOGIES INC净利率更高（-57.5% vs -265.9%，领先208.4%），Cellectis S.A.同比增速更快（375.0% vs 120.2%），Cellectis S.A.自由现金流更多（$27.6M vs $2.0M）
Cellectis S.A.是一家法国生物制药公司，专注于开发用于癌症免疫治疗的基因编辑嵌合抗原受体T细胞技术，目前在巴黎、纽约以及北卡罗来纳州罗利均设有办公机构，在肿瘤免疫基因编辑疗法领域拥有多年研发积累。
LightPath Technologies Inc是一家精密光学组件及组件生产商，主营非球面透镜、红外光学器件、光纤产品等，服务工业自动化、航空航天、国防、医疗成像、电信等领域的全球客户，提供标准及定制化光学解决方案。
CLLS vs LPTH — 直观对比
营收规模更大
LPTH
是对方的1.7倍
$9.5M
营收增速更快
CLLS
高出254.7%
120.2%
净利率更高
LPTH
高出208.4%
-265.9%
自由现金流更多
CLLS
多$25.7M
$2.0M
损益表 — Q2 FY2024 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $9.5M | $16.4M |
| 净利润 | $-25.3M | $-9.4M |
| 毛利率 | — | 36.8% |
| 营业利润率 | -181.1% | -52.6% |
| 净利率 | -265.9% | -57.5% |
| 营收同比 | 375.0% | 120.2% |
| 净利润同比 | -51.9% | -260.1% |
| 每股收益（稀释后） | $-0.28 | $-0.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLLSLPTH
| Q4 25 | — | $16.4M | ||
| Q3 25 | — | $15.1M | ||
| Q2 25 | — | $12.2M | ||
| Q1 25 | — | $9.2M | ||
| Q4 24 | — | $7.4M | ||
| Q3 24 | — | $8.4M | ||
| Q2 24 | $9.5M | $8.6M | ||
| Q1 24 | — | $7.7M |
净利润CLLSLPTH
| Q4 25 | — | $-9.4M | ||
| Q3 25 | — | $-2.9M | ||
| Q2 25 | — | $-7.1M | ||
| Q1 25 | — | $-3.6M | ||
| Q4 24 | — | $-2.6M | ||
| Q3 24 | — | $-1.6M | ||
| Q2 24 | $-25.3M | $-2.4M | ||
| Q1 24 | — | $-2.6M |
毛利率CLLSLPTH
| Q4 25 | — | 36.8% | ||
| Q3 25 | — | 29.8% | ||
| Q2 25 | — | 22.0% | ||
| Q1 25 | — | 29.1% | ||
| Q4 24 | — | 26.0% | ||
| Q3 24 | — | 33.9% | ||
| Q2 24 | — | 29.2% | ||
| Q1 24 | — | 20.9% |
营业利润率CLLSLPTH
| Q4 25 | — | -52.6% | ||
| Q3 25 | — | -16.6% | ||
| Q2 25 | — | -38.0% | ||
| Q1 25 | — | -36.3% | ||
| Q4 24 | — | -33.5% | ||
| Q3 24 | — | -16.4% | ||
| Q2 24 | -181.1% | -25.6% | ||
| Q1 24 | — | -33.6% |
净利率CLLSLPTH
| Q4 25 | — | -57.5% | ||
| Q3 25 | — | -19.2% | ||
| Q2 25 | — | -57.8% | ||
| Q1 25 | — | -39.1% | ||
| Q4 24 | — | -35.2% | ||
| Q3 24 | — | -19.3% | ||
| Q2 24 | -265.9% | -27.3% | ||
| Q1 24 | — | -33.7% |
每股收益（稀释后）CLLSLPTH
| Q4 25 | — | $-0.20 | ||
| Q3 25 | — | $-0.07 | ||
| Q2 25 | — | $0.19 | ||
| Q1 25 | — | $-0.44 | ||
| Q4 24 | — | $-0.07 | ||
| Q3 24 | — | $-0.04 | ||
| Q2 24 | $-0.28 | $-0.15 | ||
| Q1 24 | — | $-0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $149.0M | $73.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $148.6M | $77.9M |
| 总资产 | $407.1M | $148.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CLLSLPTH
| Q4 25 | — | $73.6M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $4.9M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $149.0M | — | ||
| Q1 24 | — | — |
总债务CLLSLPTH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $535.0K | ||
| Q1 24 | — | $599.4K |
股东权益CLLSLPTH
| Q4 25 | — | $77.9M | ||
| Q3 25 | — | $21.4M | ||
| Q2 25 | — | $15.6M | ||
| Q1 25 | — | $15.7M | ||
| Q4 24 | — | $26.7M | ||
| Q3 24 | — | $29.4M | ||
| Q2 24 | $148.6M | $30.2M | ||
| Q1 24 | — | $31.7M |
总资产CLLSLPTH
| Q4 25 | — | $148.6M | ||
| Q3 25 | — | $87.3M | ||
| Q2 25 | — | $81.5M | ||
| Q1 25 | — | $81.4M | ||
| Q4 24 | — | $45.8M | ||
| Q3 24 | — | $48.4M | ||
| Q2 24 | $407.1M | $48.1M | ||
| Q1 24 | — | $49.7M |
负债/权益比CLLSLPTH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.02× | ||
| Q1 24 | — | 0.02× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.9M | $2.8M |
| 自由现金流经营现金流 - 资本支出 | $27.6M | $2.0M |
| 自由现金流率自由现金流/营收 | 290.5% | 12.0% |
| 资本支出强度资本支出/营收 | 13.2% | 5.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-6.3M |
8季度趋势，按日历期对齐
经营现金流CLLSLPTH
| Q4 25 | — | $2.8M | ||
| Q3 25 | — | $-1.1M | ||
| Q2 25 | — | $-2.6M | ||
| Q1 25 | — | $-3.2M | ||
| Q4 24 | — | $-737.4K | ||
| Q3 24 | — | $-1.7M | ||
| Q2 24 | $28.9M | $64.7K | ||
| Q1 24 | — | $-394.2K |
自由现金流CLLSLPTH
| Q4 25 | — | $2.0M | ||
| Q3 25 | — | $-1.2M | ||
| Q2 25 | — | $-3.3M | ||
| Q1 25 | — | $-3.7M | ||
| Q4 24 | — | $-817.8K | ||
| Q3 24 | — | $-1.8M | ||
| Q2 24 | $27.6M | $-225.5K | ||
| Q1 24 | — | $-802.5K |
自由现金流率CLLSLPTH
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -8.1% | ||
| Q2 25 | — | -27.3% | ||
| Q1 25 | — | -40.0% | ||
| Q4 24 | — | -11.0% | ||
| Q3 24 | — | -21.2% | ||
| Q2 24 | 290.5% | -2.6% | ||
| Q1 24 | — | -10.4% |
资本支出强度CLLSLPTH
| Q4 25 | — | 5.3% | ||
| Q3 25 | — | 0.5% | ||
| Q2 25 | — | 5.6% | ||
| Q1 25 | — | 4.6% | ||
| Q4 24 | — | 1.1% | ||
| Q3 24 | — | 0.9% | ||
| Q2 24 | 13.2% | 3.4% | ||
| Q1 24 | — | 5.3% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLLS
暂无分部数据
LPTH
| Other | $7.9M | 48% |
| Infrared Components | $5.0M | 31% |
| Visible Components | $3.4M | 21% |
